• No results found

Non-invasive and transdermal measurement of blood uric acid level in human by electroporation and reverse iontophoresis

N/A
N/A
Protected

Academic year: 2020

Share "Non-invasive and transdermal measurement of blood uric acid level in human by electroporation and reverse iontophoresis"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Diffusion cell for in vitro studies.
Figure 2 Diffusion cell (diameter = 27 mm) for human studies. each electrode chamber had a diameter of 5 mm and they were 11 mm apart.
Table 1 experimental protocol for the in vitro studies
Figure 3 experimental protocol showing the time sequence for the application of electroporation, reverse iontophoresis, and sample collection.
+2

References

Related documents

Twenty-five percent of our respondents listed unilateral hearing loss as an indication for BAHA im- plantation, and only 17% routinely offered this treatment to children with

Abstract: The present protocol described extraction of active polyphenol oxidase and peroxidase from a plant rich in phenolics and chlorophylls in the

Executing either game with an adversary requires one to specify the garbling scheme, adversary, security parameter, and side-information function.. Executing game PrvSim

The EBTI was developed following steps outlined by DeVellis [31] including (a) definition of the latent construct to be measured (as described above), (b) development of an initial

The result reveals that National Commercial Banks, depositors’ influence, shareholders’ influence, liquidity and profitability are negatively associated with credit

In the analyzed group of patients operated on at the De- partment of Maxillofacial Surgery of the Frederic Chopin Clinical Regional Hospital in Rzeszów, the dominant group

Subjects applied the product once daily in the morning to the face for 21 days, and after approximately 3–5 minutes they assessed tolerability and short-term cosmetic acceptability

Flow cytometry analysis of the cell cycle showed that under the conditions used, the majority of the MCF-7 treated with DOX, 55.0% ± 1.3% of the cells were in G0/G1 phase and